(9,9-Dihexyl-9H-fluoren-2-yl)boronic acid, 97%, 250mg

1-(4-Aminopiperidin-1-yl)-2,2-dimethylpropan-1-one hydrochloride, 95.0%, 1g

Benzyl-(2,4-dimethoxy-benzyl)-amine, 95.0%, 1g

(S)-2-Amino-5-((bis(methylamino)methylene)amino)pentanoic acid, 95.0%, 1g

3-benzyl-4-(4-chlorophenyl)-4,5-dihydro-1H-1,2,4-triazole-5-thione, 250mg

3,4-Dinitrobenzoic acid, 98.0%, 5g

tert-Butyl 2-(4-aminophenoxy)ethylcarbamate, 98.0%, 5g

2-Isopropoxy-4,4,5,5-tetramethyl-1,3,2-dioxaborolane>98.0%(GC)(T)25g

Amyl Formate>95.0%(GC)25mL

4-(3-phenylpropanoyl)-1-oxa-4-azaspiro[4.5]decane-3-carboxylic acid, 95.0%, 1g

N-Benzoyl-5′-O-[bis(4-methoxyphenyl)phenylmethyl]-2′-O-methyladenosine, 95%, 25g

2-Methyl-2-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]propanenitrile, 98+%, 250mg

(S)-N-((S)-Quinuclidin-3-yl)-1,2,3,4-tetrahydronaphthalene-1-carboxamide, 97%, 1g